Dashboard
Manage Tickers

PFE


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

eli-lilly-extends-lead-in-150b-obesity-drug-race-as-novo-pfizer-clash--heres-how-etfs-stand-to-gain
Eli Lilly Extends Lead In $150B Obesity Dr...
10/30/2025 20:04:44

As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the...

Core News & Articles
'Pfizer mulls suing Metsera, Novo over top...
10/30/2025 17:38:35

https://www.semafor.com/article/10/30/2025/pfizer-mulls-suing-metsera-novo-over-topping-bid

pfizer-blasts-novo-nordisks-9-billion-counteroffer-for-metsera-as-reckless
Pfizer Blasts Novo Nordisk's $9 Billion Co...
10/30/2025 15:39:34

Novo Nordisk's $9 billion offer for Metsera challenges Pfizer's existing merger deal, prompting sharp criticism and pot...

Core News & Articles
Novo Nordisk Says Our Proposal Offers Comp...
10/30/2025 13:44:06

- Reuters 

Core News & Articles
Pfizer Deems Novo Nordisk's Metsera Propos...
10/30/2025 11:19:57

Pfizer Inc. (NYSE:PFE) is aware of the reckless and unprecedented proposal by Novo Nordisk A/S (NYSE:NVO) to acquire Metsera, I...

i-still-cant-believe-its-around-cramer-rips-plug-power
'I Still Can't Believe It's Around': Crame...
10/29/2025 11:54:36

Mad Money Lightning Round: Jim Cramer says Sempra (SRE) is a buy, supported by Wells Fargo's Overweight rating. Pfizer (PFE...

ken-paxton-alleges-johnson--johnson-misled-mothers-on-tylenol-safety
Ken Paxton Alleges Johnson & Johnson Misle...
10/28/2025 17:11:17

Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging Tylenol was deceptively marketed as safe for ...

Core News & Articles
'US Fires Top Health Official Who Opposed ...
10/28/2025 12:50:58

https://www.bloomberg.com/news/articles/2025-10-28/us-fires-top-health-official-who-opposed-widely-used-covid-shots?srnd=homepa...

wellgistics-and-datavault-team-up-to-transform-prescription-tracking
Wellgistics And DataVault Team Up To Trans...
10/22/2025 12:30:33

DataVault AI and Wellgistics Health are collaborating to bring blockchain technology to the US prescription drug market.

pfizer-canada-announces-health-canada-approval-of-abrysvo-for-adults-18-health-canada-approved-new-indication-for-abrysvo-for-use-in-adults-aged-18-59
Pfizer Canada Announces Health Canada Appr...
10/21/2025 16:04:56

With the approval of ABRYSVO® for adults aged 18+, there is now a way to help protect against RSV in a population that previous...

mark-cuban-isnt-convinced-trumprx-is-going-to-change-the-game-but-hes-giving-them-credit-for-trying
Mark Cuban Isn't Convinced TrumpRx Is Goin...
10/21/2025 05:38:41

Billionaire entrepreneur Mark Cuban offered rare praise for the Trump administration's push to lower prescription drug cost...

reported-sunday-pfizers-braftovi-plus-mektovi-delivers-476-month-median-overall-survival-in-treatment-nave-braf-v600e-mutant-lung-cancer-setting-new-long-term-benchmark
Reported Sunday, Pfizer's BRAFTOVI Plus ME...
10/20/2025 07:44:05

BRAFTOVI + MEKTOVI continued to show a substantial median overall survival benefit of 47.6 months in treatment-naïve patients w...

Core News & Articles
Reported Sunday, Pfizer And Astellas Repor...
10/20/2025 07:41:36

The probability of survival at 8 years was an unprecedented 78.9% with XTANDI plus leuprolide versus 69.5% with leuprolide, in ...

invo-fertility-stock-is-plunging-after-white-house-announcement
Invo Fertility Stock Is Plunging After Whi...
10/17/2025 18:37:05

INVO Fertility Inc (NASDAQ:IVF) shares are trading lower on Thursday as investors book profits following White House announceme...

uk-health-agency-recommends-gsk-backed-viiv-healthcares-apretude-as-injectable-hiv-treatment
UK Health Agency Recommends GSK-Backed Vii...
10/17/2025 16:43:32

NICE recommends ViiV Healthcare's Apretude as the first injectable PrEP for HIV prevention, offering an alternative to dail...

novo-vs-lilly-vs-pfizer-who-wins-if-trump-slashes-the-price-of-weight-loss-drugs
Novo Vs. Lilly Vs. Pfizer: Who Wins If Tru...
10/17/2025 14:19:58

Trump's promise to cut cost of Novo Nordisk A/S drug Ozempic from $1,300 to $150 shakes GLP-1 gold rush, with potential imp...

reported-earlier-pfizer-ceo-says-us-pharma-industry-needs-to-collaborate-with-china--reuters
Reported Earlier: 'Pfizer CEO says US phar...
10/15/2025 11:43:40

https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-ceo-says-us-pharma-industry-needs-collaborate-with-china-202...

wall-streets-most-accurate-analysts-spotlight-on-3-health-care-stocks-with-over-3-dividend-yields
Wall Street's Most Accurate Analysts Spotl...
10/15/2025 11:15:13

pfizer-seeks-expanded-use-approval-for-breast-cancer-drug
Pfizer Seeks Expanded Use Approval For Bre...
10/14/2025 17:37:12

Pfizer's Tukysa improved progression-free survival in first-line HER2+ metastatic breast cancer, showing strong efficacy an...

hedge-fund-shah-capital-urges-novavax-to-consider-sale-amid-vaccine-rollout-struggles-sees-5-billion-potential
Hedge Fund Shah Capital Urges Novavax To C...
10/14/2025 17:08:17

Shah Capital urges Novavax to consider a sale after poor COVID-19 vaccine rollout, highlighting the potential value of at least...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION